Clinical Trial

Oral Tranexamic Acid and Laser for Treatment of Melasma

Study Description

Oral Tranexamic Acid and Laser for Treatment of Melasma

Tranexamic acid and 1927 diode laser non-ablative fractionated laser for the treatment of Melasma.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Tranexamic Acid

A split face study of oral tranexamic acid in combination with laser treatment

Additional Information

Official Study Title

The Efficacy of Oral Tranexamic Acid and a 1927 nm Diode Laser in Patients With Melasma. A Prospective Randomized Split Face Study

Clinical Trial ID

NCT03686787

ParticipAid ID

aADMOe